| Value | ₹6.99 Cr |
|---|
NSE filing, NSE: ZENITHDRUG. Summary written from the filing by ALFA Finder's alert engine.
Zenith Drugs Ltd: key numbers
- Share price
- ₹37.00
- Market cap
- ₹63.45 Cr
- Revenue (annual)
- ₹171.2 Cr
- Net profit (annual)
- ₹3.94 Cr
- P/E (TTM)
- 16.1×Sector 46.1×
- Promoter holding
- 69.98%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zenith Drugs Ltd
All →Zenith Drugs Business Update
Zenith Drugs Board approved sale of a 5-hectare property in Indore for ₹13.75 Crore to ACE Engineering & Chemicals Pvt Ltd. Completion expected by November 2026.
- Value
- ₹13.75 Cr
Zenith Drugs Bags New Order from Haryana Medical Services Corporation Limited
Zenith Drugs Limited has been awarded a tender by Haryana Medical Services Corporation Limited to supply medicines for two years at Rs. 11.15 per unit.
- From
- Haryana Medical Services Corporation Limited
- Execution
- 2 years
Zenith Drugs Annual General Meeting
Zenith Drugs Limited released the voting results and Scrutinizer's Report for its 26th Annual General Meeting conducted on September 29, 2026.
Zenith Drugs Annual General Meeting
Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.
Zenith Drugs Board Meeting Outcome
Zenith Drugs Limited announced the notice for its 26th AGM and appointed a secretarial auditor and a scrutinizer for the meeting.
Zenith Drugs Capital Structure Change
Zenith Drugs Limited's board approved the allotment of 16,09,050 convertible warrants to promoters on a preferential basis. The aggregate consideration for this issuance is Rs. 6.99 Crore.
- Value
- ₹7.00 Cr
Other capital structure change announcements
All →Emkay Global Financial Services Capital Structure Change
Emkay Global will invest ₹30.00 Crore in cash in wholly owned subsidiary Emkay Capital. The related-party deal completes within 90 days.
- Value
- ₹30.00 Cr
- Execution
- Within 90 days
OnEMI Technology Solutions Capital Structure Change
OnEMI will invest ₹624.15 Crore in its wholly owned subsidiary Si Creva via rights subscription. Funds come from preferential issue proceeds, completing by December 2026.
- Value
- ₹624.1 Cr
- Execution
- By end of December 2026
Meesho Capital Structure Change
Meesho approved up to Rs.400 Crore capital infusion into its wholly owned subsidiary, Meesho Payments. Board also approved a new subsidiary and further Kirana Club investments.
- Value
- ₹400.0 Cr
Womancart Capital Structure Change
Womancart Limited submitted its draft letter of offer for a rights issue of up to Rs.1,200 lakhs to eligible shareholders. The issue is pending in-principle approval from NSE Emerge, with the price, ratio and dates still blank.
- Value
- ₹12.00 Cr
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Great Eastern Shipping Company Capital Structure Change
Great Eastern Shipping bought back 88,877 equity shares on 28 October 2026 at an average of Rs.1,529.71. Total shares bought back under the open-market buyback now stand at 38,48,494.
- Value
- ₹13.60 Cr